Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	No Prophylaxis	198
Overall Study	STARTED	Naproxen 500 mg BID	200
Overall Study	STARTED	Loratadine 10 mg QD	202
Overall Study	Received Pegfilgrastim	No Prophylaxis	191
Overall Study	Received Pegfilgrastim	Naproxen 500 mg BID	196
Overall Study	Received Pegfilgrastim	Loratadine 10 mg QD	200
Overall Study	Received Naproxen / Loratadine	No Prophylaxis	0
Overall Study	Received Naproxen / Loratadine	Naproxen 500 mg BID	193
Overall Study	Received Naproxen / Loratadine	Loratadine 10 mg QD	198
Overall Study	COMPLETED	No Prophylaxis	160
Overall Study	COMPLETED	Naproxen 500 mg BID	171
Overall Study	COMPLETED	Loratadine 10 mg QD	181
Overall Study	NOT COMPLETED	No Prophylaxis	38
Overall Study	NOT COMPLETED	Naproxen 500 mg BID	29
Overall Study	NOT COMPLETED	Loratadine 10 mg QD	21

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01712009/flow